2nd International Congress on Neuropathic Pain
|Event Date/Time: Jun 07, 2007||End Date/Time: Jun 10, 2007|
Research and management of neuropathic pain is currently at an important crossroad. Basic scientists have suggested a switch from a diagnosis-oriented approach to a mechanism-based approach for treatment. Advances in neuroimaging, clinical neurophysiology, neuroimmunology, and quantitative sensory testing allow more precise assessment of such mechanisms in individual patients. Drugs that target these mechanisms are the aim of R&D programs in many pharmaceutical companies. These drug therapies compete with traditional and new neuroaugmentative or neuroablative surgical techniques. Regulatory agencies are setting guidelines for the approval of treatment paradigms specific for neuropathic pain. Important clinical trials with new drugs have started to yield promising results, giving rise to the hope that formerly "intractable" neuropathic pain syndromes may finally be alleviated. At the same time we gain more insight into the epidemiology of neuropathic pain in many neurological disorders, and into ways of preventing some of the neuropathic pain conditions.